secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2022-03-02T23:59:59+00:00
Accession:  0001193125-22-063143
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad closes $1.2B senior notes offering (3.300% 2027 & 3.700% 2032)
----------------------------------------------------------------------

- $400M 3.300% notes due 2027 and $800M 3.700% notes due 2032 issued at par.
- Net proceeds of approximately $1.186 billion after underwriting discount and expenses.
- Proceeds for general corporate purposes, including working capital, capex, and potential M&A.
- Joint book-runners: Citigroup Global Markets, Goldman Sachs, J.P. Morgan Securities.
- Closing date March 2, 2022; offering pursuant to shelf registration statement on Form S-3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/0001193125-22-063143-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000119312522063143/d254235d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-063143

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer